Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$3K Hold
600
﹤0.01% 9915
2014
Q2
$3K Sell
600
-1,400
-70% -$8.33K ﹤0.01% 9947
2014
Q1
$15K Sell
2,000
-1,500
-43% -$11K ﹤0.01% 8491
2013
Q4
$25K Buy
3,500
+300
+9% +$2.23K ﹤0.01% 7897
2013
Q3
$25K Sell
3,200
-6,600
-67% -$51.3K ﹤0.01% 7793
2013
Q2
$64K Buy
+9,800
New +$61.6K ﹤0.01% 6437

Other funds holding ELX

UBS's ELX Position: Q3 2014 in Review

UBS reduced its EMULEX CORP (ELX) stake by 3.3% in Q3 2014, selling an estimated $4.91K and leaving 26,786 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #5654.

UBS first reported a position in ELX in Q2 2013 and has held it in 6 quarters since. The position peaked at $183K in Q2 2013. 147 funds tracked by Wall St. Rank hold ELX as of Q3 2014.

  • UBS held 26,786 shares of EMULEX CORP worth $132K as of Q3 2014.
  • UBS sold 907 EMULEX CORP shares in Q3 2014, an estimated $4.91K.
  • EMULEX CORP made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5654 holding.
  • UBS first reported a position in EMULEX CORP in Q2 2013 and has held it in 6 quarters since.
  • UBS's EMULEX CORP position peaked at $183K in Q2 2013.
  • 147 funds tracked by Wall St. Rank held EMULEX CORP as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.